Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ETON
Eton Pharmaceutcials, Inc. Common Stock
stock NASDAQ

At Close
Aug 7, 2026 3:59:53 PM EDT
44.57USD-3.486%(-1.61)277,988
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-46.18)0
After-hours
Aug 7, 2026 4:05:30 PM EDT
44.55USD-0.045%(-0.02)49,208
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 23, 2022
11:03AM EST  The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More   Benzinga
Dec 20, 2021
07:41AM EST  Eton Pharma And ANI Pharma Announce Commercial Availability Of Carglumic Acid Tablets   RTTNews
07:31AM EST  Eton Pharmaceuticals And ANI Pharmaceuticals Announce Commercial Availability Of Carglumic Acid Tablets, The First And Only FDA-Approved Generic Version Of Carbaglu   Benzinga
07:30AM EST  -- Product is now available exclusively through Anovo specialty pharmacy -- Product is stable at room temperature while Carbaglu requires refrigeration -- Eton Cares patient support program will offer $0 co-pays to commercial insurance patients   GlobeNewswire Inc
Nov 18, 2021
02:04PM EST  Small Pharma Strengthens Board With Appointment of Paul Maier as   GlobeNewswire Inc
Nov 15, 2021
06:20PM EST  Eton Pharmaceuticals Q3 EPS $(0.24) Misses $(0.13) Estimate, Sales $775.00K Miss $3.04M Estimate   Benzinga
04:05PM EST  Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the third quarter ended September 30, 2021.   GlobeNewswire Inc
11:07AM EST  Earnings Scheduled For November 15, 2021   Benzinga
10:49AM EST  Eton Pharmaceuticals Announces Co-Promotion Agreement With Tolmar Pharmaceuticals For ALKINDI SPRINKLE   Benzinga
10:37AM EST  The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More   Benzinga
06:30AM EST  Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar   GlobeNewswire Inc
Nov 8, 2021
07:02AM EST  Eton Pharmaceuticals Inc (ETON) and Azurity Pharmaceuticals, Inc. on Monday said the U.S. Food and Drug Administration approved Eprontia oral solution.   RTTNews
06:26AM EST  Eton Pharma And Azurity Pharma Announce FDA Approval Of EPRONTIA Oral Solution For 3 Indications   RTTNews
06:07AM EST  Eton Pharmaceuticals And Azurity Pharmaceuticals, Inc. Announce FDA Approval Of EPRONTIA Oral Solution   Benzinga
06:00AM EST  Eton Pharmaceuticals, Inc (Nasdaq: ETON) and Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EPRONTIA (topiramate) oral solution, 25mg/mL.   GlobeNewswire Inc
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 28, 2021
07:54AM EDT  Eton Pharmaceuticals Acquires US Marketing Rights To Approved Orphan Drug Product Carglumic Acid   Benzinga
07:30AM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has acquired U.S. marketing rights to carglumic acid tablets.   GlobeNewswire Inc
Oct 1, 2021
11:15AM EDT  How Bad Are Eton Pharmaceuticals's Earnings? | Return On Capital Employed   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 16, 2021
04:16PM EDT  Eton Pharmaceuticals Q2 EPS $(0.08) Beats $(0.14) Estimate, Sales $3.07M Miss $3.81M Estimate   Benzinga
04:02PM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the second quarter ended June 30, 2021.   GlobeNewswire Inc
04:04AM EDT  Earnings Scheduled For August 16, 2021   Benzinga
Aug 15, 2021
12:16PM EDT  The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow   Benzinga
11:06AM EDT  The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 11, 2021
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
Aug 10, 2021
07:55AM EDT  The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 4, 2021
09:02AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Aug. 4, 2021: BYSI, FSLY, BBIG, WEBR, ETON   Benzinga
Aug 3, 2021
04:05PM EDT  Eton Pharmaceuticals to Report Second Quarter 2021 Financial   GlobeNewswire Inc
Aug 2, 2021
06:10PM EDT  Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates   Benzinga
Aug 1, 2021
11:19AM EDT  The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jun 16, 2021
08:20AM EDT  The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO   Benzinga
06:43AM EDT  Eton Pharmaceuticals Buys US, Canadian Rights To Zeneo Hydrocortisone Autoinjector   Benzinga
Jun 15, 2021
04:08PM EDT  Eton Pharmaceuticals Acquires U.S., Canadian Rights To ZENEO Hydrocortisone Autoinjector   Benzinga
04:05PM EDT  -- Expands Etons Adrenal Insufficiency Orphan Drug Portfolio -- ZENEO Hydrocortisone is Expected to be the First and Only Hydrocortisone Autoinjector for Patients Requiring Emergency Hydrocortisone -- Proprietary ZENEO Needleless Device is Covered by 24 U.S. Patents Extending as Far as 2037   GlobeNewswire Inc
11:54AM EDT  Eton Pharma Stock Is Trading Higher After FDA Approval For Rezipres   Benzinga
10:45AM EDT  Eton Pharmaceuticals Announces FDA Approval Of Rezipres (Ephedrine Hydrochloride Injection); Shares Set To Resume Trade At 11:10 a.m. EDT   Benzinga
10:38AM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia.   GlobeNewswire Inc
Jun 2, 2021
10:38AM EDT  Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates   Benzinga
May 28, 2021
08:37AM EDT  Eton Pharmaceuticals Stock Tumbles After FDA Rejects its Dehydrated Alcohol Injection Application For Methanol Poisoning   Benzinga
08:06AM EDT  Eton Pharmaceuticals Receives Complete Response Letter From FDA For Dehydrated Alcohol Injection; FDA Determined Application Cannot Be Approved In Present Form   Benzinga
08:05AM EDT  Eton Pharmaceuticals Receives Complete Response Letter from U.S.   GlobeNewswire Inc
May 23, 2021
10:06AM EDT  The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation   Benzinga
May 13, 2021
04:52PM EDT  Eton Pharmaceuticals: Q1 Earnings Insights   Benzinga
04:26PM EDT  Eton Pharmaceuticals Q1 EPS $0.19, Inline, Sales $11.90M Miss $12.05M Estimate   Benzinga
04:05PM EDT  -- First quarter 2021 revenue of $11.9 million -- First quarter 2021 operating earnings of $5.4 million; EPS of $0.19 -- Eton now has three commercial, revenue-generating products   GlobeNewswire Inc
08:10AM EDT  The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use   Benzinga
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 4, 2021
04:05PM EDT  Eton Pharmaceuticals to Report First Quarter 2021 Financial   GlobeNewswire Inc
Apr 15, 2021
02:43PM EDT  Mid-Afternoon Market Update: Gold Jumps 1.8%; Dell Shares Spike Higher   Benzinga
Apr 8, 2021
08:12AM EDT  Eton Pharmaceuticals On Apr. 8 Entered Underwriting Agreement With National Securities Corporation And Harrow Health Relating To Public Offering Of 1.32M Shares By Harrow   Benzinga
Mar 17, 2021
04:05PM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it has appointed Jenn Adams to its board of directors effective March 17, 2021. Ms. Adams brings extensive commercial, operational, and leadership experience in the pharmaceutical industry.   GlobeNewswire Inc
06:48AM EDT  HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $14   Benzinga
Mar 16, 2021
04:02PM EDT  Eton Pharmaceuticals Q4 EPS $(0.32) Misses $(0.26) Estimate, Sales $81.00K Miss $1.33M Estimate   Benzinga
04:02PM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on business progress.   GlobeNewswire Inc
08:17AM EDT  The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study   Benzinga
04:46AM EDT  Earnings Scheduled For March 16, 2021   Benzinga
Mar 14, 2021
08:14AM EDT  Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations   Benzinga
Mar 4, 2021
04:05PM EST  Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2020   GlobeNewswire Inc
Feb 16, 2021
04:05PM EST  Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that company management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference from February 24th through February 26th.   GlobeNewswire Inc
Feb 10, 2021
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 9, 2021
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 8, 2021
09:29AM EST  Eton Pharmaceuticals Offloads Neurology Portfolio To Azurity Pharmaceuticals For $45M   Benzinga
08:11AM EST  Eton Pharmaceuticals Announces Sale Of Neurology Portfolio; Co. To Receive Up To $45M Plus Royalties   Benzinga
08:09AM EST  Eton Sells Its Neurology Portfolio To Azurity Pharmaceuticals   RTTNews
08:00AM EST  -- Eton to receive up to $45 million plus royalties on product sales   GlobeNewswire Inc
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 14, 2021
08:20AM EST  Eton Acquires Canadian Rights To ALKINDI SPRINKLE From Diurnal Group   RTTNews
08:08AM EST  Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI SPRINKLE From Diurnal Group   Benzinga
08:00AM EST  Eton Pharmaceuticals Announces Acquisition of Canadian Rights for   GlobeNewswire Inc
Jan 4, 2021
07:16AM EST  10 Biggest Price Target Changes For Monday   Benzinga
06:13AM EST  HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $15   Benzinga
Dec 29, 2020
08:09AM EST  The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica   Benzinga
Dec 17, 2020
08:03AM EST  Eton Pharmaceuticals Announces Acceptance For Filing Of New Drug Application For Topiramate Oral Solution   Benzinga
08:00AM EST  Eton Pharmaceuticals Announces Acceptance for Filing of New Drug   GlobeNewswire Inc
Nov 24, 2020
09:04AM EST  Eton Pharma Reports Availability Of Orphan Drug ALKINDI SPRINKLE In US   Benzinga
09:00AM EST  -- ALKINDI SPRINKLE is now exclusively available through AnovoRx Specialty Pharmacy. To support patient access to ALKINDI SPRINKLE, Eton has established the Eton Cares Program.   GlobeNewswire Inc
Nov 12, 2020
04:27PM EST  Eton Pharmaceuticals Q3 EPS $(0.31) Misses $(0.25) Estimate, Sales $161.00K   Benzinga
07:44AM EST  The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal   Benzinga
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Nov 4, 2020
04:06PM EST  Eton Pharmaceuticals to Report Third Quarter Financial Results on   GlobeNewswire Inc
Oct 16, 2020
04:05PM EDT  Eton Pharmaceuticals Announces Closing of Public Offering   GlobeNewswire Inc
Oct 15, 2020
08:39AM EDT  Eton Reports Acceptance For Filing Of NDA For Zonisamide Oral Suspension   RTTNews
08:32AM EDT  Eton Pharmaceuticals Announces Acceptance For Filing Of New Drug Application For Zonisamide Oral Suspension   Benzinga
08:30AM EDT  Eton Pharmaceuticals Announces Acceptance for Filing of New Drug   GlobeNewswire Inc
Oct 14, 2020
08:36AM EDT  Eton Pharma Prices 2.8M Shares At $7/Share   Benzinga
08:30AM EDT  Eton Pharmaceuticals Prices Underwritten Public Offering of Common   GlobeNewswire Inc
Oct 13, 2020
04:03PM EDT  Eton Pharmaceuticals Announces Proposed Public Offering Of Common Stock; Terms Not Disclosed   Benzinga
04:01PM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The offering is expected to price on or about Wednesday, October 14, 2020.   GlobeNewswire Inc
Oct 8, 2020
08:04AM EDT  Eton Pharmaceuticals Announces Acceptance For Filing Of New Drug Application For Orphan Drug Dehydrated Alcohol Injection   Benzinga
08:00AM EDT  Eton Pharmaceuticals Announces Acceptance for Filing of New Drug   GlobeNewswire Inc
Oct 6, 2020
04:07PM EDT  Eton Pharmaceuticals Submits New Drug Application To FDA For Topiramate Oral Solution (ET-101)   Benzinga
04:05PM EDT  - Application Submitted for the Treatment of Partial-Onset Seizures and Migraine   GlobeNewswire Inc
Sep 30, 2020
10:31AM EDT  Return On Capital Employed Overview: Eton Pharmaceuticals   Benzinga
08:33AM EDT  10 Biggest Price Target Changes For Wednesday   Benzinga
06:50AM EDT  HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $20   Benzinga
Sep 29, 2020
07:23PM EDT  Eton Pharmaceuticals Shares Spike Higher After Co Announces FDA Approval of ALKINDI SPRINKLE as Replacement Therapy in Pediatric Patients with Adrenocortical Insufficiency   Benzinga
07:15PM EDT  Eton Pharmaceuticals Announced FDA Approval of Orphan Drug ALKINDI SPRINKLE (hydrocortisone) as Replacement Therapy in Pediatric Patients with Adrenocortical Insufficiency; Shares to Resume at 7:20 PM ET   Benzinga
06:50PM EDT  -ALKINDI SPRINKLE is the first and only FDA-approved granular hydrocortisone formulation for adrenocortical insufficiency specifically designed for children   GlobeNewswire Inc
Sep 25, 2020
11:26AM EDT  Eton, Bausch Win FDA Approval For Preservative-Free Allergy Eyedrops   Benzinga
08:06AM EDT  Eton Pharma Shares To Resume Trade At 8:30 a.m. EDT   Benzinga
08:03AM EDT  FDA Oks Bausch + Lomb Alaway Preservative Free Ophthalmic Solution, 0.035%   RTTNews
08:02AM EDT  FDA Approves Bausch + LombAlaway Preservative Free (Ketotifen Fumarate) Ophthalmic Solution, 0.035%; NOTE: An Affiliate Of Bausch Health Acquired The US Rights To Alaway Preservative Free From Eton In 2019   Benzinga
08:01AM EDT  FDA Approves Bausch + Lomb Alaway(r) Preservative Free (Ketotifen Fumarate)   PR Newswire
06:59AM EDT  Eton Pharma Shares Halted News Pending   Benzinga
Sep 21, 2020
08:13AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Monday, Sept. 21, 2020: TSLA, NKLA, BTI, GIS, ETON   Benzinga
Sep 16, 2020
09:02AM EDT  Eton Pharma Reports Its Partner Has Not Yet Received Communication From FDA Related To Decision On Review Of EM-100   Benzinga
09:00AM EDT  Eton Pharmaceuticals Provides Update on the FDA Review of EM-100   GlobeNewswire Inc
Aug 31, 2020
08:09AM EDT  Eton Pharmaceuticals Appoints Ingrid Hoos As SVP Of Scientific Affairs   RTTNews
08:00AM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it has appointed Ingrid Hoos as the companys new Senior Vice President of Scientific Affairs. In the new role, Ms. Hoos will support the companys regulatory, product development, and quality activities.   GlobeNewswire Inc
Aug 12, 2020
08:46AM EDT  Recap: Eton Pharmaceuticals Q2 Earnings   Benzinga
08:34AM EDT  Eton Pharmaceuticals Q2 EPS $(0.23) Beats $(0.26) Estimate, Sales $20.00K Miss $290.00K Estimate   Benzinga
08:30AM EDT  Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today reported financial results for the second quarter ended June 30, 2020 and provided an update on business progress.   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 12, 2020   Benzinga
Aug 11, 2020
09:18AM EDT  Eton Pharma Reports Its Partner Has Not Received Communication From FDA Related To Decision On Review Of EM-100; Target Action Date Was Aug. 10; Co. Says Is Not Aware Of Any Info Requests Outstanding, Sees FDA Communicating Decision In Coming Days   Benzinga
09:00AM EDT  Eton Pharmaceuticals Provides Update on the FDA Review of EM-100   GlobeNewswire Inc
Aug 10, 2020
04:45PM EDT  04:45 Monday, August 10, 2020   RTTNews
10:19AM EDT  Shares of Eton Pharmaceuticals, Inc. (ETON) are rising almost 16 percent or $1.05 in Monday's morning trade at $7.69, after earlier touching a new 52-week high of $8.73 despite the absence of any specific news that could move the stock.   RTTNews
05:52AM EDT  Eton Pharmaceuticals Trading +37% Premarket Ahead of FDA Decision on EM-100 for Allergic Conjunctivitis   Benzinga
Aug 4, 2020
04:10PM EDT  Eton Pharmaceuticals to Report Second Quarter Financial Results on   GlobeNewswire Inc
Jul 30, 2020
08:20AM EDT  Eton Pharmaceuticals Submits New Drug Application To FDA For Zonisamide Oral Suspension (ET-104)   Benzinga
08:00AM EDT  - Application Submitted for the Treatment of Partial Seizures in Epilepsy Patients   GlobeNewswire Inc
Jul 28, 2020
11:29AM EDT  Eton Pharmaceuticals shares are trading higher following a report suggesting the company was awarded a 5-year contract from Veterans Affairs. Terms were not disclosed.   Benzinga
10:50AM EDT  Eton Pharmaceuticals Awarded 5 Year Contract From Veterans Affairs, Price Not Disclosed   Benzinga
Jul 27, 2020
07:31AM EDT  Eton Pharmaceuticals Submits New Drug Application To FDA For Orphan Drug Dehydrated Alcohol Injection (DS-100)   Benzinga
07:30AM EDT  -Granted Orphan Drug Designation by the FDA for the Treatment of Methanol Poisoning   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC